[Interview: questions to professeur Dominique Valla].
Valla
D
D
D000925:Anticoagulants / Q000627:therapeutic use; D006502:Budd-Chiari Syndrome / Q000150:complications / Q000175:diagnosis / Q000601:surgery / Q000628:therapy; D003267:Contraception; D000075202:Contraindications; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006975:Hypertension, Portal / Q000473:pathology; D008099:Liver / Q000473:pathology*; D016031:Liver Transplantation; D008297:Male; D009196:Myeloproliferative Disorders / Q000150:complications / Q000175:diagnosis; D011168:Portal System / Q000473:pathology; D011169:Portal Vein / Q000473:pathology; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D011247:Pregnancy; D012189:Retrospective Studies; D012307:Risk Factors; D012598:Sclerosis; D015607:Stents; D020246:Venous Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D014812:Vitamin K; D006493:Heparin